Vocal Biomarkers Market is estimated to be US$ 1.65 billion by 2030 with a CAGR of 14.1%

Nehashaikh26 May, 2022News

Global Vocal Biomarkers Market accounted for US$ 1.65 billion in 2020 and is estimated to be US$ 6.18 billion by 2030 and is anticipated to register a CAGR of 14.1%. Non-invasive vocal biomarkers are used to detect illnesses using speech features. Its use is based on the premise that severe psychological problems, neurophysiologic changes, and other factors have an impact on motor control and, as a result, modify speech production by modifying speech features. A symptom or medical condition of the human body is referred to as a biomarker. It is the pattern of speech in the case of vocal biomarkers. Furthermore, due to its noninvasive nature, voice biomarkers would be more cost effective than traditional biomarkers, which are pricey and place a major healthcare burden on governments and insurance payer organizations.